Patient Direct public Access via referral from health Like other biologicals, Like biological, access Like other biological, access access to products professional in absence of access normally via normally via referral from access normally via referral in the absence of advertising to the public (?) referral from health health professional. from health professional. any on professional. Whether patient access is Whether patient access is In the absence of good advertising affected will depend on extent Whether patient access is affected will depend on extent clinical evidence, products directly to to which currently available affected will depend on to which currently available likely not to be included, at consumers. treatments involve extent to which currently treatments involve homologous least in the short term, so Patient access homologous and minimally available treatments and minimally manipulated patient access likely to be unlikely to be manipulated products. involve homologous and products and comply with any affected. affected. minimally manipulated applicable standards. products and comply with any applicable standards.
Patient access Direct public access to products in the absence of any on advertising directly to consumers. Patient access unlikely to be affected. Access via referral from health professional in absence of advertising to the public (?) Whether patient access is affected will depend on extent to which currently available treatments involve homologous and minimally manipulated products. Like other biologicals, access normally via referral from health professional. Whether patient access is affected will depend on extent to which currently available treatments involve homologous and minimally manipulated products and comply with any applicable standards. Like biological, access normally via referral from health professional. Whether patient access is affected will depend on extent to which currently available treatments involve homologous and minimally manipulated products and comply with any applicable standards. Like other biological, access normally via referral from health professional. In the absence of good clinical evidence, products likely not to be included, at least in the short term, so patient access likely to be affected.
consult-autologous-stem-cell-150106.docx